BR0315650A - Vetor lócus de expressão elevada com base no lócus do gene de cadeia pesada de ferritina - Google Patents

Vetor lócus de expressão elevada com base no lócus do gene de cadeia pesada de ferritina

Info

Publication number
BR0315650A
BR0315650A BR0315650-8A BR0315650A BR0315650A BR 0315650 A BR0315650 A BR 0315650A BR 0315650 A BR0315650 A BR 0315650A BR 0315650 A BR0315650 A BR 0315650A
Authority
BR
Brazil
Prior art keywords
heavy chain
locus
ferritin heavy
high expression
vector based
Prior art date
Application number
BR0315650-8A
Other languages
English (en)
Inventor
Holly Prentice
Original Assignee
Biogen Idec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Idec Inc filed Critical Biogen Idec Inc
Publication of BR0315650A publication Critical patent/BR0315650A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/80—Vectors comprising a special translation-regulating system from vertebrates
    • C12N2840/85—Vectors comprising a special translation-regulating system from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"VETOR LOCUS DE EXPRESSãO ELEVADA COM BASE NO LóCUS DO GENE DE CADEIA PESADA DE FERRITINA". A apresente invenção refere-se a vetores lócus de expressão elevada com base, em parte, no lócus de cadeia pesada de ferritina. Os vetores incluem seq³ências de flanqueamento 5<39> distais e/ou seq³ências reguladoras 5<39> proximais derivadas do lócus de cadeia pesada de ferritina. Os vetores incluem um sítio para a inserção de seq³ências heterólogas e seq³ências reguladoras 3<39> proximais e de flanqueamento 3<39> distais. As seq³ências reguladoras 3<39> proximais e de flanqueamento 3<39> distais são opcionalmente derivadas do lócus de cadeia pesada de ferritina. As células transformadas com os vetores e métodos de produção de proteínas heterólogas codificadas pelos vetores, são também apresentadas.
BR0315650-8A 2002-10-24 2003-10-22 Vetor lócus de expressão elevada com base no lócus do gene de cadeia pesada de ferritina BR0315650A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42125202P 2002-10-24 2002-10-24
PCT/US2003/033433 WO2004037982A2 (en) 2002-10-24 2003-10-22 High expression locus vector based on ferritin heavy chain gene locus

Publications (1)

Publication Number Publication Date
BR0315650A true BR0315650A (pt) 2005-09-20

Family

ID=32176688

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315650-8A BR0315650A (pt) 2002-10-24 2003-10-22 Vetor lócus de expressão elevada com base no lócus do gene de cadeia pesada de ferritina

Country Status (18)

Country Link
US (1) US20070031920A1 (pt)
EP (1) EP1558725A4 (pt)
JP (1) JP2006503583A (pt)
KR (1) KR20050084867A (pt)
CN (1) CN1732258A (pt)
AU (1) AU2003286577B2 (pt)
BR (1) BR0315650A (pt)
CA (1) CA2503437A1 (pt)
EA (1) EA008222B1 (pt)
GE (1) GEP20084388B (pt)
IS (1) IS7797A (pt)
MX (1) MXPA05004163A (pt)
NO (1) NO20052481L (pt)
NZ (1) NZ539423A (pt)
PL (1) PL376561A1 (pt)
RS (1) RS20050367A (pt)
WO (1) WO2004037982A2 (pt)
ZA (1) ZA200502986B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10655133B2 (en) 2014-01-21 2020-05-19 Synplogen Co., Ltd. Method for preparing DNA unit composition, and method for creating concatenated DNA

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740461A (en) * 1983-12-27 1988-04-26 Genetics Institute, Inc. Vectors and methods for transformation of eucaryotic cells
DE3856559T2 (de) * 1987-05-21 2004-04-29 Micromet Ag Multifunktionelle Proteine mit vorbestimmter Zielsetzung
US5672510A (en) * 1990-01-19 1997-09-30 Genetic Therapy, Inc. Retroviral vectors
US6225290B1 (en) * 1996-09-19 2001-05-01 The Regents Of The University Of California Systemic gene therapy by intestinal cell transformation
DE10006886A1 (de) * 2000-02-16 2001-08-23 Hepavec Ag Fuer Gentherapie Nichthumaner helferabhängiger Virusvektor
NZ528003A (en) * 2001-05-30 2006-09-29 Chromos Molecular Systems Inc Platform artificial chromosome expression systems (ACes) containing single or multiple site-specific recombination sites

Also Published As

Publication number Publication date
NO20052481L (no) 2005-07-25
PL376561A1 (pl) 2006-01-09
GEP20084388B (en) 2008-06-10
ZA200502986B (en) 2005-10-20
EA008222B1 (ru) 2007-04-27
CN1732258A (zh) 2006-02-08
NZ539423A (en) 2006-12-22
KR20050084867A (ko) 2005-08-29
WO2004037982A2 (en) 2004-05-06
AU2003286577B2 (en) 2008-09-04
IS7797A (is) 2005-04-11
WO2004037982A3 (en) 2004-09-30
US20070031920A1 (en) 2007-02-08
RS20050367A (en) 2007-08-03
CA2503437A1 (en) 2004-05-06
EP1558725A4 (en) 2006-11-08
NO20052481D0 (no) 2005-05-23
JP2006503583A (ja) 2006-02-02
EA200500700A1 (ru) 2005-10-27
AU2003286577A1 (en) 2004-05-13
EP1558725A2 (en) 2005-08-03
MXPA05004163A (es) 2005-10-05

Similar Documents

Publication Publication Date Title
DK1548032T3 (da) KDR-peptider og vacciner indeholdende disse
BRPI9913360B8 (pt) proteína de uricase recombinante quimérica, molécula de ácido nucléico isolada e purificada, vetor e célula hospedeira transformada.
PH12021551122A1 (en) Method for treating muscular dystrophy by targeting utrophin gene
WO2003080807A3 (en) Compositions and methods for suppressing eukaryotic gene expression
BR0007414A (pt) Expressão e exportação de proteìnas antiobesidade como proteìnas de fusão fc
CY1111431T1 (el) Μεταλλαγμενες πρωτεϊνες πλακουντιου αυξητικου παραγοντα τυπου 1, μεθοδος παρασκευης και εφαρμογες αυτων
DE60230456D1 (de) Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren
DK2289533T3 (da) Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider
ATE532861T1 (de) Expressionsvektor
DE69838681D1 (de) Escherichia coli hochexpressionsvektor
UA92913C2 (ru) Экспрессионный вектор и способы продуцирования высоких уровней белков
WO2002092758A8 (en) Gastrokines and derived peptides including inhibitors
BR0315650A (pt) Vetor lócus de expressão elevada com base no lócus do gene de cadeia pesada de ferritina
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2003027290A1 (fr) Procede pour conferer ou reguler la fertilite d&#39;un cytoplasme a sterilite male de riz bt au moyen d&#39;un gene de restauration de la fertilite, et procede d&#39;estimation de la presence d&#39;un gene de restauration de la fertilite
DE60329115D1 (de) Tumorantigenprotein und dessen verwendung
WO2005105838A3 (en) Ion channel
WO2004024190A3 (en) Recombinant lentivirale vector pseudotyped with the hemagglutinin protein for gene transfer into the retina
DE60321443D1 (de) Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
AU2001237201A1 (en) Human source gene leading sequence, gene vector and gene expression strategy
WO2004003209A3 (fr) Acide nucleique isole du 5&#39;ntr du gene fgf-1 humain presentant une activite ires

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal: dismissal of application maintained